Welcome to CRWENewswire, Stocks to Watch for Tuesday December 13th, 2011. I am Shalika Jayasekera. On its first quarter fiscal 2012 results, Synergetics USA Inc - SURG - posted sales of $13.5 million, [...]

Welcome to CRWENewswire, Stocks to Watch for Tuesday December 13th, 2011. I am Shalika Jayasekera. On its first quarter fiscal 2012 results, Synergetics USA Inc - SURG - posted sales of $13.5 million, a 12.0% increase year over year, and net income from continuing operations increased 81.3% to $1.2 million compared to the same period the prior year. Repros Therapeutics Inc - RPRX - provided top line results for the end of dosing analysis on its Phase 2 clinical study of Androxal in hypogonadal men with type 2 diabetes. Trials completed by the company have shown that unlike testosterone replacement therapy, Androxal stimulates normal production of the male hormone by the testes. and finally; UniTek Global Services Inc - UNTK - reported that it has been awarded a three-year turf agreement in the Northeast region with a major wireless carrier. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera